Endothelin-1 Enriched Tumor Phenotype Predicts Breast Cancer Recurrence

<table>Kaplan-Meier curves for outcomes. Disease-free survival (DFS) in breast cancer patients with ET-1 non-enriched (blue, solid line) and ET-1-enriched tumor phenotype (red, broken line).</table>

International Scholarly Research Notices

fig2

Figure 2

Figure 2: Endothelin-1 Enriched Tumor Phenotype Predicts Breast Cancer Recurrence 